KalGene Inc Overview

  • Founded

  • 2007

Founded
  • Status

  • Private

  • Employees

  • 2

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $4.76M

  • Investors

  • 13

KalGene Inc General Information

Description

Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an antibody-based approach. The company's therapeutics are aimed at improving clinical and survival efficacy through the use of personalized medicine to overcome safety issues, enabling physicians to alleviate patient suffering during treatment as well as improve the overall quality of life.

Contact Information

Website
www.kalgene.com
Formerly Known As
KalGene Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 6100 Royalmount Avenue
  • NRC Building
  • Montreal, Quebec H4P 2R2
  • Canada
+1 (416) 000-0000

KalGene Inc Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KalGene Inc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 20-Jan-2022 $4.76M 00.000 Completed Product Development
7. Secondary Transaction - Private 01-Jan-2020 00.000 Completed Product Development
6. Later Stage VC (Series A) 27-Nov-2017 00.000 00.000 Completed Product Development
5. Accelerator/Incubator Completed Startup
4. Accelerator/Incubator 11-May-2016 Completed Startup
3. Grant 05-Jun-2015 00.000 Completed Startup
2. Grant 23-Mar-2012 $130K Completed Startup
1. Accelerator/Incubator Completed Startup
To view KalGene Inc’s complete valuation and funding history, request access »

KalGene Inc Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an
Drug Discovery
Montreal, Canada
2 As of 2022
00.000
0000000000 0 00.000

000000

ud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00

000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000 000000000
Bethlehem, PA
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KalGene Inc Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
000000 00000000000 Venture Capital-Backed Bethlehem, PA 000.00 0000000000 000.00
0000000 Venture Capital-Backed Singapore, Singapore 00 00000 00000000000 00000
000000 0000 000000 Corporation New York, NY 00 00.00 000000 - 000 00.00
000000 00000000000 Corporate Backed or Acquired Aliso Viejo, CA 000 0000 000000&0 0000
You’re viewing 5 of 41 competitors. Get the full list »

KalGene Inc Executive Team (5)

Name Title Board Seat Contact Info
Nickolay Kukekov Ph.D President, Chief Executive Officer & Board Member
Jeff Irwin Chief Financial Officer
Anthony Giovinazzo Executive Chairman
Albert Agro Ph.D Acting Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

KalGene Inc Board Members (7)

Name Representing Role Since
Anthony Giovinazzo KalGene Inc Executive Chairman 000 0000
Benoit Cyr Self Board Member 000 0000
Jacki Jenuth Ph.D Lumira Ventures Board Member 000 0000
Michal Prywata KalGene Inc Board Member 000 0000
Nickolay Kukekov Ph.D KalGene Inc President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

KalGene Inc Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KalGene Inc Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Chenel Capital Family Office 000 0000 000000 0
Kyto Technology And Life Science Corporation Minority 000 0000 000000 0
adMare BioInnovations VC-Backed Company Minority 000 0000 000000 0
Anges Québec Angel Group Minority 000 0000 000000 0
AQC Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial